AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia

202062 citationsJournal Articlebronze Open Access

Authors

AMG-176 is active in inducing CLL cell death while sparing normal blood cells. Combination with low-dose venetoclax was additive or synergistic.

Good health and well-being

Published in: Clinical Cancer Research

Volume 26, Issue 14, pp. 3856-3867

Field-Weighted Citation Impact: 5.78